Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Mitchell

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Journal for Immunotherapy of Cancer|June 26, 2020
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hotSimon P Keam, Heloise Halse, Thu Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal CancerMichael Michael, Rachel Wong, Sanjeev Gill, et al.
The Journal of Clinical Investigation|May 11, 2011
Mitochondrial dysfunction in patients with primary congenital insulin resistanceAlison Sleigh, Philippa Raymond-Barker, Kerrie Thackray, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
The American Journal of Surgical Pathology|January 15, 2026
Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupBibianna Purgina, Elena Di Blasi, Paola Collini, et al.
Infectious Disease Reports|September 25, 2021
Variables Associated with Coronavirus Disease 2019 Vaccine Hesitancy Amongst Patients with Neurological DisordersArash Ghaffari-Rafi, Kimberly Bergenholtz Teehera, Tate Justin Higashihara, et al.
Clinical & Translational Immunology|May 8, 2020
High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancerMinyu Wang, Yu-Kuan Huang, Joseph Ch Kong, et al.
Annals of Surgical Oncology|July 14, 2025
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology|August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology|July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Journal for Immunotherapy of Cancer|June 26, 2020
High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hotSimon P Keam, Heloise Halse, Thu Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal CancerMichael Michael, Rachel Wong, Sanjeev Gill, et al.
The Journal of Clinical Investigation|May 11, 2011
Mitochondrial dysfunction in patients with primary congenital insulin resistanceAlison Sleigh, Philippa Raymond-Barker, Kerrie Thackray, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
The American Journal of Surgical Pathology|January 15, 2026
Pathologic Assessment of Retroperitoneal Sarcomas: A Position Paper By the Transatlantic Australasian Retroperitoneal Sarcoma Working GroupBibianna Purgina, Elena Di Blasi, Paola Collini, et al.
Infectious Disease Reports|September 25, 2021
Variables Associated with Coronavirus Disease 2019 Vaccine Hesitancy Amongst Patients with Neurological DisordersArash Ghaffari-Rafi, Kimberly Bergenholtz Teehera, Tate Justin Higashihara, et al.
Clinical & Translational Immunology|May 8, 2020
High-dimensional analyses reveal a distinct role of T-cell subsets in the immune microenvironment of gastric cancerMinyu Wang, Yu-Kuan Huang, Joseph Ch Kong, et al.
Annals of Surgical Oncology|July 14, 2025
Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology|August 31, 2025
ASO Visual Abstract: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PECOMA): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Annals of Surgical Oncology|July 29, 2025
Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)Eyal Mor, Sameer Apte, Catherine Mitchell, et al.
Pageof 12